CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Elevated endocannabinoid levels in liver fibrosis are driven by diminished hepatic expression and activity of endocannabinoid degrading enzymes
DOI 10.1055/s-0029-1246368
Bibliografische Angaben
Nachweis in CareLit
Autor:innenSV Siegmund, A Wojtalla, F Herweck, A Zimmer, MV Singer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: We and others have previously shown, that the hepatic endocannabinoid (EC) system becomes activated during fibrogenensis. In particular, the expression of cannabinoid receptors and levels of ECs (anandamide, AEA; 2-arachydonoyl glycerol, 2-AG) are upregulated. However, the mechanisms that lead to the increased levels of ECs during liver fibrogenensis are unknown. AIM: We sought to analyse the hepatic expressio…
Zitieren
Zitierempfehlung
SV Siegmund, A Wojtalla, F Herweck, A Zimmer, MV Singer (2010) Elevated endocannabinoid levels in liver fibrosis are driven by diminished hepatic expression and activity of endocannabinoid degrading enzymes. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0029-1246368
Mit CareLit weiterarbeiten